• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MPTP暴露1年后帕金森病猴黑质致密部中活跃小胶质细胞的证据。

Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure.

作者信息

Barcia Carlos, Sánchez Bahillo Angel, Fernández-Villalba Emiliano, Bautista Víctor, Poza Y Poza Máximo, Fernández-Barreiro Andrés, Hirsch Etienne C, Herrero María-Trinidad

机构信息

Experimental Neurology and Neurosurgery Group, Department of Human Anatomy and Psychobiology, School of Medicine, University of Murcia, Murcia, Spain.

出版信息

Glia. 2004 May;46(4):402-9. doi: 10.1002/glia.20015.

DOI:10.1002/glia.20015
PMID:15095370
Abstract

Inflammatory changes have been found in Parkinson's disease, in humans intoxicated with the parkinsonian toxin MPTP, and in animal models of the disease. However, it is still not known whether inflammatory changes are responsible for active nerve cell death or if they have a protective role against neurodegeneration. In this study, we analyzed the glial reaction in the substantia nigra pars compacta (SNpc) and the striatum of monkeys rendered parkinsosian by chronic MPTP injections. At postmortem examination 1 year after the last MPTP injection, the density of astroglial cells and activated microglial cells in the SNpc, but not in the striatum, of MPTP-intoxicated animals was significantly higher than in the two control animals. These data suggest that neurodegeneration was still active despite the absence of the agent triggering cell death and that the glial reaction is associated with long-term neurodegeneration.

摘要

在帕金森病患者、被帕金森病毒素MPTP中毒的人类以及该疾病的动物模型中均发现了炎症变化。然而,目前仍不清楚炎症变化是导致神经细胞主动死亡的原因,还是对神经退行性变具有保护作用。在本研究中,我们分析了通过慢性注射MPTP诱导帕金森病的猴子黑质致密部(SNpc)和纹状体中的胶质反应。在最后一次注射MPTP后1年进行尸检时,MPTP中毒动物的SNpc中星形胶质细胞和活化小胶质细胞的密度显著高于两只对照动物,而纹状体中的密度则无显著差异。这些数据表明,尽管引发细胞死亡的因素已不存在,但神经退行性变仍在进行,且胶质反应与长期神经退行性变相关。

相似文献

1
Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure.MPTP暴露1年后帕金森病猴黑质致密部中活跃小胶质细胞的证据。
Glia. 2004 May;46(4):402-9. doi: 10.1002/glia.20015.
2
Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.S-100蛋白的表达与MPTP处理的小鼠神经元损伤有关。
Glia. 2003 May;42(3):307-13. doi: 10.1002/glia.10225.
3
Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.帕金森病1-甲基-4-苯基-1,2,3,6-四氢吡啶/丙磺舒渐进性神经退行性小鼠模型黑质致密部神经元凋亡的早期迹象。
Neuroscience. 2006 Jun 19;140(1):67-76. doi: 10.1016/j.neuroscience.2006.02.007. Epub 2006 Mar 14.
4
Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.在给予1-甲基-4-苯基-1,2,3,6-四氢吡啶后,小鼠纹状体和黑质中的小胶质细胞出现持久的反应性变化。
Brain Res. 2007 Mar 23;1138:196-202. doi: 10.1016/j.brainres.2006.12.054. Epub 2006 Dec 23.
5
Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment.1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)处理后小鼠黑质中犬尿氨酸转氨酶-I(KAT-I)表达降低。
Neuroscience. 2004;126(4):899-914. doi: 10.1016/j.neuroscience.2004.04.043.
6
Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.白细胞介素-18基因敲除小鼠在急性给予1-甲基-4-苯基-1,2,3,6-四氢吡啶治疗后,小胶质细胞活化减弱,多巴胺能神经元损失减少。
Neuroscience. 2004;128(2):451-8. doi: 10.1016/j.neuroscience.2004.07.020.
7
Neuroprotection in Parkinson models varies with toxin administration protocol.帕金森病模型中的神经保护作用因毒素给药方案而异。
Eur J Neurosci. 2006 Dec;24(11):3174-82. doi: 10.1111/j.1460-9568.2006.05192.x.
8
Acute and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys.急性和慢性给予1-甲基-4-苯基-1,2,3,6-四氢吡啶会在猴子黑质中引发相似的小胶质细胞激活。
J Neuropathol Exp Neurol. 2009 Sep;68(9):977-84. doi: 10.1097/NEN.0b013e3181b35e41.
9
Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.在帕金森病动物模型中,艾塞那肽-4通过抑制小胶质细胞活化和基质金属蛋白酶-3表达来保护多巴胺能神经元。
J Endocrinol. 2009 Sep;202(3):431-9. doi: 10.1677/JOE-09-0132. Epub 2009 Jul 1.
10
The 6-hydroxydopamine-induced nigrostriatal neurodegeneration produces microglia-like NG2 glial cells in the rat substantia nigra.6-羟多巴胺诱导的黑质纹状体神经退行性变使大鼠黑质中出现类似于小胶质细胞的 NG2 神经胶质细胞。
Glia. 2010 Nov 1;58(14):1686-700. doi: 10.1002/glia.21040.

引用本文的文献

1
Intercellular Adhesion Molecule 1 (ICAM-1): An Inflammatory Regulator with Potential Implications in Ferroptosis and Parkinson's Disease.细胞间黏附分子 1(ICAM-1):一种具有潜在意义的炎症调节剂,与铁死亡和帕金森病有关。
Cells. 2024 Sep 15;13(18):1554. doi: 10.3390/cells13181554.
2
Therapeutic Implications and Regulations of Protein Post-translational Modifications in Parkinsons Disease.帕金森病中蛋白质翻译后修饰的治疗意义和调控。
Cell Mol Neurobiol. 2024 Jul 3;44(1):53. doi: 10.1007/s10571-024-01471-8.
3
Oxidative Stress and Neurodegeneration: Insights and Therapeutic Strategies for Parkinson's Disease.
氧化应激与神经退行性变:帕金森病的见解与治疗策略
Neurol Int. 2024 Apr 29;16(3):502-517. doi: 10.3390/neurolint16030037.
4
Pinostrobin mitigates neurodegeneration through an up-regulation of antioxidants and GDNF in a rat model of Parkinson's disease.在帕金森病大鼠模型中,松属素通过上调抗氧化剂和胶质细胞源性神经营养因子减轻神经退行性变。
F1000Res. 2023 Oct 27;12:846. doi: 10.12688/f1000research.134891.2. eCollection 2023.
5
The Impact of microRNAs on Mitochondrial Function and Immunity: Relevance to Parkinson's Disease.微小RNA对线粒体功能和免疫的影响:与帕金森病的相关性
Biomedicines. 2023 May 3;11(5):1349. doi: 10.3390/biomedicines11051349.
6
7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate.7-硝基吲唑可减少非人类帕金森病灵长类动物的 L-多巴诱导的运动障碍。
Open Biol. 2023 May;13(5):220370. doi: 10.1098/rsob.220370. Epub 2023 May 17.
7
Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson's Disease.NURR1 调控的神经炎症在帕金森病中的作用研究进展。
Int J Mol Sci. 2022 Dec 19;23(24):16184. doi: 10.3390/ijms232416184.
8
Pharmacological, Biochemical and Immunological Studies on Protective Effect of Mangiferin in 6-Hydroxydopamine (6-OHDA)-Induced Parkinson's Disease in Rats.芒果苷对6-羟基多巴胺(6-OHDA)诱导的大鼠帕金森病保护作用的药理、生化及免疫学研究
Ann Neurosci. 2021 Jul;28(3-4):137-149. doi: 10.1177/09727531211051976. Epub 2021 Nov 2.
9
Emerging Roles for Aberrant Astrocytic Calcium Signals in Parkinson's Disease.异常星形胶质细胞钙信号在帕金森病中的新作用
Front Physiol. 2022 Jan 11;12:812212. doi: 10.3389/fphys.2021.812212. eCollection 2021.
10
GCH1 Deficiency Activates Brain Innate Immune Response and Impairs Tyrosine Hydroxylase Homeostasis.GCH1 缺乏会激活大脑固有免疫反应并损害酪氨酸羟化酶的动态平衡。
J Neurosci. 2022 Jan 26;42(4):702-716. doi: 10.1523/JNEUROSCI.0653-21.2021. Epub 2021 Dec 7.